Characterization of Glioblastomas in Young Adults

作者: B.K. Kleinschmidt-DeMasters , Lynne Meltesen , Loris McGavran , Kevin O. Lillehei

DOI: 10.1111/J.1750-3639.2006.00029.X

关键词:

摘要: Most adult glioblastoma multiformes (GBMs) present in patients 45-70 years old; tumors occurring at the extremes of age spectrum are uncommon, and seldom studied. We hypothesized that young-adult GBMs would differ from elderly-adult pediatric GBMs. Cases were identified 1997 to 2005. Demographic histological features, MIB-1 TP53 immunohistochemical findings epidermal growth factor receptor (EGFR) amplification status by fluorescence situ hybridization compiled correlated with survival. Twenty-eight (74%) our 38 GBM had primary de novo tumors, two which occurred cancer syndromes. Two additional radiation-induced eight (21%) secondary Seven as long-term (>3 years) survivors. Six cases manifested unusual morphological including three epithelioid GBMs, one rhabdoid GBM, gliosarcoma small cell containing abundant, refractile, eosinophilic inclusions. index emerged most important prognosticator survival (P < 0.005). Although there was a trend between extent necrosis, expression, EGFR survival, none reached statistical significance. young adults more inhomogeneous tumor group than older show features overlap both

参考文章(46)
Peter C. Burger, Dennis K. Pearl, Kenneth Aldape, Allan J. Yates, Bernd W. Scheithauer, Sandra M. Passe, Robert B. Jenkins, C. David James, Small Cell Architecture—A Histological Equivalent of EGFR Amplification in Glioblastoma Multiforme? Journal of Neuropathology and Experimental Neurology. ,vol. 60, pp. 1099- 1104 ,(2001) , 10.1093/JNEN/60.11.1099
Jürgen A. Kraus, Matthias Wenghoefer, Nicole Glesmann, Svenja Mohr, Martina Beck, Matthias C. Schmidt, Rolf Schröder, Ute Berweiler, Wolfgang Roggendorf, Sabine Diete, Knut Dietzmann, Karlheinz Heuser, Bettina Müller, Rolf Fimmers, Andreas von Deimling, Uwe Schlegel, TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme. Journal of Neuro-oncology. ,vol. 52, pp. 263- 272 ,(2001) , 10.1023/A:1010684203704
Maurizio Salvati, Luigi Cervoni, Marco Artico, Riccardo Caruso, Franco Maria Gagliardi, Long-term survival in patients with supratentorial glioblastoma Journal of Neuro-oncology. ,vol. 36, pp. 61- 64 ,(1998) , 10.1023/A:1017926603341
Meena B. Bhattacharjee, Janet M. Bruner, p53 protein in pediatric malignant astrocytomas: A study of 21 patients Journal of Neuro-oncology. ,vol. 32, pp. 225- 233 ,(1997) , 10.1023/A:1005727902387
Matthias C. Schmidt, Sven Antweiler, Nina Urban, Wolf Mueller, A. Kuklik, Birgit Meyer-Puttlitz, Otmar D. Wiestler, David N. Louis, Rolf Fimmers, Andreas von Deimling, Impact of Genotype and Morphology on the Prognosis of Glioblastoma Journal of Neuropathology and Experimental Neurology. ,vol. 61, pp. 321- 328 ,(2002) , 10.1093/JNEN/61.4.321
Hiroko Ohgaki, Paul Kleihues, Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology. ,vol. 64, pp. 479- 489 ,(2005) , 10.1093/JNEN/64.6.479
R A Prayson, H H Morris rd, Anaplastic pleomorphic xanthoastrocytoma Archives of Pathology & Laboratory Medicine. ,vol. 122, pp. 1082- 1086 ,(1998)
Michael J. Winger, David R. Macdonald, J. Gregory Cairncross, Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. Journal of Neurosurgery. ,vol. 71, pp. 487- 493 ,(1989) , 10.3171/JNS.1989.71.4.0487
Kathleen R. Lamborn, Burt G. Feuerstein, Ken D. Aldape, Michael Prados, Eric C. Burton, Robert B. Jenkins, James Scott, Peter Forsyth, Sandra Passe, Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Research. ,vol. 62, pp. 6205- 6210 ,(2002)
Maarten C.C.M. Hulshof, Radboud W. Koot, Eric C. Schimmel, Fido Dekker, D. Andries Bosch, Dionisio González González, Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Strahlentherapie Und Onkologie. ,vol. 177, pp. 283- 290 ,(2001) , 10.1007/PL00002409